Objectives: To report and name firstly that there are cardiovascular disease (CVD), diabetes mellitus (DM) and cancers (CDC) strips; and disclose their mechanisms, classifications, and clinical significances.
Study Design: Narrative and systematic review study and interpretive analysis.
Data Sources And Study Selection: to collect and present related evidences on CDC strips from evidence-based, open-access, both Chinese- and English-language literatures in recent 10 years on clinical trials from PubMed according to keywords "CVD, DM and cancers" as well as authors' extensive clinical experience with the treatment of more than fifty thousands of patients with CVD, diabetes and cancers over the past decades, and analyze their related mechanisms and categories which based on authors' previous works.
Data Extraction: data were mainly extracted from 48 articles which are listed in the reference section of this review. Qualitative, quantitative and mixed data were included, narratively and systematically reviewed.
Results: With several conceptual and technical breakthrough, authors present related evidences on CDC strips, these are, CVD and DM, DM and cancers, cancers and CVD linked, respectively; And "Bad SEED" +/- "bad soil" theory or doctrine may explain this phenomenon due to "internal environmental injure, abnormal or unbalance" in human body resulting from the role of risk factors (RFs) related multi-pathways and multi-targets, which including organ & tissue (e.g., vascular-specific), cell and gene-based mechanisms. Their classifications include main strips/type B, and Branches/type A as showed by tables and figures in this article.
Conclusions: There are CDC strips and related mechanisms and classifications. CDC strips may help us to understand, prevent, and control related common non-communicable diseases (NCDs) as well as these high risk strips.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4178114 | PMC |
| http://dx.doi.org/10.3978/j.issn.2072-1439.2014.07.15 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Drug overdose deaths among women 1999-2021 in the United States: Differences by race, ethnicity, and age.
Womens Health (Lond)
December 2024
Department of Human Development and Family Studies and Family Studies, The Pennsylvania State University, University Park, PA, USA.
Background: The U.S. drug overdose epidemic is increasingly severe and steep increases have been seen among women.
View Article and Find Full Text PDFCandida auris MIC testing by EUCAST and clinical and laboratory standards institute broth microdilution, and gradient diffusion strips; to be or not to be amphotericin B resistant?
Clin Microbiol Infect
January 2025
Department Pathology and Laboratory Medicine, University of Texas Health San Antonio, San Antonio, TX, USA.
Objectives: Reported amphotericin B resistance rates for Candida auris vary considerably. This may reflect clinically relevant differences in susceptibility, technical issues with testing, or adoption of a clinical breakpoint that bisects the wild-type population. We compared reference methods and two gradient diffusion strips using a shared C.
View Article and Find Full Text PDFEffects of Adopting Preventive Drug Lists on Medication Costs and Disparities by Income Over 2 Years: A Natural Experiment for Translation in Diabetes (NEXT-D) Study.
Diabetes Care
October 2024
Department of Population Medicine, Harvard Pilgrim Health Care Institute, Boston, MA.
Objective: To examine the association between preventive drug lists (PDLs) and changes in medication costs among patients with diabetes insured in commercial health plans over 2 follow-up years.
Research Design And Methods: We conducted a quasiexperimental study using the Optum deidentified Clinformatics Data Mart Database (January 2003 to December 2017). The intervention group included 5,582 patients with diabetes age 12-64 years switched by employers to PDL coverage; the control group included 5,582 matched patients whose employers offered no PDL.
Evaluation of gradient strip diffusion for susceptibility testing of aztreonam-avibactam in metallo-β-lactamase-producing Enterobacterales.
J Clin Microbiol
November 2024
Northwell Health Clinical Laboratories, New York, New York, USA.
The emergence of metallo-β-lactamase (MBL)-producing Enterobacterales presents unique clinical treatment challenges. Recently developed β-lactam/ β-lactamase inhibitor combination agents, while effective against other carbapenemase-producing organisms, are notably ineffective against MBL producers. While MBLs do not hydrolyze monobactams (aztreonam), many MBL-producing organisms are resistant to aztreonam through alternate mechanisms, leaving cefiderocol as the sole monotherapy treatment option recommended for MBL producers.
View Article and Find Full Text PDFEvaluation of Etest and MICRONAUT-AM Assay for Antifungal Susceptibility Testing of : Underestimation of Fluconazole Resistance by MICRONAUT-AM and Overestimation of Amphotericin B Resistance by Etest.
Antibiotics (Basel)
September 2024
Department of Microbiology, Faculty of Medicine, Kuwait University, Safat 13110, Kuwait.
Article Synopsis
- Recent outbreaks of multidrug-resistant fungi in healthcare settings highlight the need for effective antifungal susceptibility testing (AST) to manage invasive infections.* -
- The study compared the performance of Etest and broth microdilution-based MICRONAUT-AM-EUCAST assays by testing 121 clinical isolates, revealing significant discrepancies in fluconazole and amphotericin B resistance assessments.* -
- Findings suggest that MCN-AM underestimates fluconazole resistance, while Etest overestimates amphotericin B resistance, indicating a need for method-specific resistance breakpoints to improve clinical outcomes.*
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!